News

Stay up to date on our latest stories.

Filters

Hikma launches a generic version of Afinitor® Tablets, 2.5mg, 5mg, 7.5mg

Press Release, Product
Hikma launches a generic version of Afinitor® Tablets, 2.5mg, 5mg, 7.5mg

Hikma launches Dicyclomine Hydrochloride Oral Solution

Press Release, Product
Hikma launches Dicyclomine Hydrochloride Oral Solution

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP

Press Release, Product
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP

Hikma launches employee matching donation campaign to support local US food banks and pantries

Press Release, Corporate
Hikma launches employee matching donation campaign to support local US food banks and pantries

Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain di...

Press Release, Corporate
Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain di...

Hikma launches Buprenorphine Hydrochloride Injection

Press Release, Corporate
Hikma launches Buprenorphine Hydrochloride Injection

Hikma launches Nicardipine Hydrochloride premixed injection in ready to use bags

Press Release, Corporate
Hikma launches Nicardipine Hydrochloride premixed injection in ready to use bags

Hikma appoints Douglas Hurt as Director

Press Release, Corporate
Hikma appoints Douglas Hurt as Director

Hikma announces strong start to 2020 and reiterates full year guidance

Press Release, Corporate
Hikma announces strong start to 2020 and reiterates full year guidance

Hikma update regarding COVID-19

Press Release, Corporate
Hikma update regarding COVID-19

Hikma launches Vecuronium Bromide for Injection

Press Release, Product
Hikma launches Vecuronium Bromide for Injection

Hikma supports teachers in Jordan through new partnership with Save the Children

Press Release, Responsibility
Hikma supports teachers in Jordan through new partnership with Save the Children

Hikma expands generics portfolio with Everolimus Tablets launch

Press Release, Product
Hikma expands generics portfolio with Everolimus Tablets launch

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL...

Press Release, Corporate
Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL...

Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Aller...

Press Release, Corporate
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Aller...